Xenetic Biosciences, Inc. Financial Ratios
XBIO|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-65.9%
Profit Margin
-158.4%
Net Income / Revenue
Asset Turnover
0.30
Revenue / Total Assets
Equity Multiplier
1.39
Total Assets / Equity
Composite: -65.9% (reported: -65.9%)
Profitability
Liquidity
Current Ratio
8.32
Quick Ratio
8.32
Solvency
Interest Coverage
-11.28
Efficiency
Asset Turnover
0.30
Inventory Turnover
-
Days Sales Outstanding
-
As of FY2025 · SEC 10-K Annual Filings · Last checked Jun 28, 2026
Earnings Quality
Accrual Ratio
-15.0%
-14.7pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.